Rapid and simple method for the analysis of nateglinide in human plasma using HPLC analysis with UV detection.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Pharmaceutical and Biomedical Analysis

• Publication date

  2003-03-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0731-7085(02)00680-5PMID 12615243
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and metabolism of nateglinide in humans.

  2001cited by this paper
• Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus.

  2000cited by this paper
• Single‐Dose Pharmacokinetics of Nateglinide in Subjects with Hepatic Cirrhosis

  2000cited by this paper
• The Effect of Food on the Oral Bioavailability and the Pharmacodynamic Actions of the Insulinotropic Agent Nateglinide in Healthy Subjects

  1999cited by this paper
• Determination of N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine and its metabolites in human plasma and urine by column-switching high-performance liquid chromatography with ultraviolet detection.

  1997cited by this paper
• The ability of a new hypoglycaemic agent, A‐4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic β‐cells under metabolic inhibition

  1997cited by this paper
• Determination of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine in human plasma by solid-phase extraction and column-switching high-performance liquid chromatography with ultraviolet detection.

  1996cited by this paper
• Structure determination of metabolites isolated from urine and bile after administration of AY4166, a novel D-phenylalanine-derivative hypoglycemic agent.

  1996cited by this paper
• A novel D-phenylalanine-derivative hypoglycemic agent A-4166 increases cytosolic free Ca2+ in rat pancreatic beta-cells by stimulating Ca2+ influx.

  1994cited by this paper

• Structural similarity-based search for glinides exhibiting cis- and trans-inhibitory activity toward uric acid transporter 1.

  2025cites this paper
• Development and Validation of a Green Spectrofluorimetric Method for Nateglinide Quantification: Utilizing AR87 as a Probe With Box-Behnken Optimization and Quantum Mechanical Calculations.

  2025cites this paper
• Nateglinide: A comprehensive profile.

  2025cites this paper
• An Isocratic RP-HPLC Method for Simultaneous Quantification of Nateglinide and Furosemide: Application to In Vitro Caco-2 Intestinal Permeability Studies of Nanodrugs.

  2025cites this paper
• Hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry combined with fabric phase sorptive extraction for therapeutic drug monitoring of pioglitazone, repaglinide, and nateglinide in human plasma.

  2023cites this paper
• Identification and characterization of degradation products of Nateglinide

  2022cites this paper
• TO STUDY THE PHARMACOKINETIC HERB-DRUG INTERACTION OF MOMORDICA CHARANTIA FRUIT EXTRACT AND PURE CHARANTIN WITH NATEGLINIDE IN RATS

  2021cites this paper
• Analysis Of Vildagliptin And Nateglinide For Simultaneous Estimation Using Spectro-Chromatographic Methods

  2020cites this paper
• Stability Indicating UV Spectrophotometric Methods for the Determination of Nateglinide in Pharmaceuticals

  2018cites this paper
• A Review of Analytical Methods for the Determination of Nateglinide in Pharmaceuticals and Biological Samples

  2016cites this paper
• Chapter Three - Carbamazepine

  2016cites this paper
• development and validation of HPLC method for determination of nateglinide in drug substances

  2015cites this paper
• Development and validation of an HPLC method for determination of nateglinide in drug substances

  2015cites this paper
• Spectrofluorimetric determination of nateglinide in pure and pharmaceutical preparations through derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole

  2014cites this paper
• Development and Validation of High Performance Liquid Chromatographic Method for the Determination of Nateglinide in Human Plasma by HPLC-UV Detection

  2014cites this paper
• QUANTITATIVE ESTIMATION OF NATEGLINIDE IN PHARMACEUTICAL DOSAGE FORMS BY VISIBLE SPECTROPHOTOMETRY

  2013cites this paper
• SPECTROPHOTOMETRIC METHODS FOR ESTIMATION OF NATEGLINIDE IN BULK DRUG AND ITS DOSAGE FORM

  2013cites this paper
• Synthesis and characterization of carboxymethyl chitosan hydrogel: application as pH-sensitive delivery for nateglinide.

  2012cites this paper
• Effect of Piperine on Antihyperglycemic Activity and Pharmacokinetic Profile of Nateglinide

  2012cites this paper
• A validated high-performance liquid chromatographic method for the determination of levodopa in rat plasma & its application in pharmacokinetic studies

  2012cites this paper
• RP-UPLC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF NATEGLINIDE IN BULK DRUG AND PHARMACEUTICAL FORMULATIONS: A QUALITY BY DESIGN APPROACH

  2012cites this paper
• Stability-indicating HPTLC method for simultaneous determination of nateglinide and metformin hydrochloride in pharmaceutical dosage form.

  2011cites this paper
• Determination of Nateglinide in Human Plasma by LC-ESI-MS and Its Application to Bioequivalence Study

  2010cites this paper
• Determination of the L-enantiomer of nateglinide in pharmaceutical formulations by micellar electrokinetic chromatography

  2010cites this paper
• Bioequivalence of GLUNATE®Tablet to PASTIC®Tablet (nateglinide 90 mg)

  2009cites this paper
• Spectrophotometric determination of nateglinide in bulk and tablet dosage forms

  2009cites this paper
• Development of a New Analytical Method for Determination of Related Components in Nateglinide

  2008cites this paper
• Chapter 9 Other therapeutic drugs of forensic relevance

  2008cites this paper
• Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of nateglinide, cilostazol and its active metabolite 3,4-dehydro-cilostazol in Wistar rat plasma and its application to pharmacokinetic study.

  2008cites this paper
• Determination of mitiglinide in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry

  2007influential citation
• A Validated Stability Indicating LC Method for Nateglinide

  2007cites this paper
• Nateglinide quantification in rabbit plasma by HPLC: optimization and application to pharmacokinetic study.

  2007cites this paper
• Determination of metolazone in human blood by liquid chromatography with electrospray ionization tandem mass spectrometry.

  2007cites this paper
• Determination of nateglinide in human plasma by high-performance liquid chromatography with pre-column derivatization using a coumarin-type fluorescent reagent.

  2007cites this paper
• Determination of nateglinide in animal plasma by micellar electrokinetic chromatography and on-line sweeping technique.

  2004cites this paper
• Recent Developments of Achiral HPLC Methods in Pharmaceuticals Using Various Detection Modes

  2004cites this paper
• Influence of CYP2C9 and CYP2D6 Polymorphisms on the Pharmacokinetics of Nateglinide in Genotyped Healthy Volunteers

  2004cites this paper